Tracing a path to ethylene: Ethylene is produced industrially from fossil carbon sources, but plants and microbes produce small amounts through a handful of unusual enzymatic reactions. Copeland et al . studied a microbial ethylene-forming enzyme using oxygen isotope–tracing experiments and biochemical assays to test mechanistic proposals. This enzyme, which uses a non–heme iron center to activate oxygen, catalyzes two distinct oxidation reactions with different mechanisms. One reaction is entirely off-pathway and results in fragmentation of a co-substrate, arginine. The other reaction can completely fragment 2-oxoglutarate into ethylene, bicarbonate, and two molecules of carbon dioxide; however, it occasionally derails and yields an omega–hydroxy acid product. —MAF
26 November 2019 in Journal of the American Chemical Society
The enzymatic late-stage functionalization of C(sp3)-H bonds has emerged as a transformative strategy in medicinal chemistry. Verruculogen synthase (FtmOx1) is known to catalyze the endoperoxidation of its native substrate, fumitremorgin B. Here, we demonstrate the catalytic versatility of FtmOx1 by showing its ability to mediate diverse C(sp3)-H transformations on non-native substrates—phenethylamine and tetrahydroisoquinoline derivatives (1) —including β-hydroxylation, β-ketone formation, dealkylation, and α,β-desaturation. A total of 48 structurally diverse substrates prove suitable for this method, substantially expanding the biocatalytic repertoire of FtmOx1. Mechanistic studies, combined with crystallographic and mutagenesis analyses, reveal the distinct molecular basis for this diverse C(sp3)-H oxyfunctionalization compared to native pathway. Notably, the relative flexibility of the phenethyl and benzyl chains of 1, assisted by specific substitutions that allow the two chains to swing, enables high β-selectivity for hydroxylation and prevents secondary oxidation. This C(sp3)-H activation platform efficiently generates structurally diverse oxyfunctionalized derivatives, including 1,2-amino alcohols (2), 1,2-amino ketones (3), and enamines (4), accelerating lead discovery for modulators of the human relaxin family peptide receptor 4 (RXFP4). Collectively, our work establishes FtmOx1 as a powerful biocatalytic tool, expanding the frontiers of C–H functionalization in drug discovery.
14 August 2026 in Journal of the American Chemical Society